Free Trial

Crocs (NASDAQ:CROX) Stock Crosses Above 200 Day Moving Average - Should You Sell?

Crocs logo with Consumer Discretionary background
Image from MarketBeat Media, LLC.

Key Points

  • Crocs shares climbed above their 200-day moving average of $116.05, trading as high as $117.82 and last changing hands at $116.84.
  • Analysts maintain a “Moderate Buy” consensus, with an average price target of $139.10; ratings range from Goldman Sachs’ $95 sell target to bullish targets as high as $163.
  • Crocs exceeded quarterly earnings and revenue estimates, reporting $4.55 in EPS and $1.18 billion in revenue, while guiding to fiscal 2026 EPS of $13.70–$14.00.
  • Five stocks we like better than Crocs.

Crocs, Inc. (NASDAQ:CROX - Get Free Report) shares passed above its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $116.05 and traded as high as $117.82. Crocs shares last traded at $116.84, with a volume of 1,026,798 shares trading hands.

Analyst Ratings Changes

CROX has been the subject of a number of research reports. Robert W. Baird set a $163.00 target price on Crocs in a report on Friday, July 31st. The Goldman Sachs Group reiterated a "sell" rating and set a $95.00 price objective on shares of Crocs in a report on Friday, July 31st. UBS Group boosted their target price on Crocs from $107.00 to $120.00 and gave the company a "neutral" rating in a research note on Friday, July 31st. Barclays upped their price target on Crocs from $110.00 to $118.00 and gave the stock an "equal weight" rating in a research report on Friday, July 31st. Finally, Bank of America lifted their price objective on shares of Crocs from $145.00 to $160.00 and gave the company a "buy" rating in a report on Thursday, July 23rd. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Crocs has an average rating of "Moderate Buy" and an average target price of $139.10.

Get Our Latest Analysis on Crocs

Crocs Stock Up 1.4%

The company has a debt-to-equity ratio of 0.94, a current ratio of 1.49 and a quick ratio of 0.96. The firm has a 50-day moving average of $122.97 and a 200 day moving average of $116.05. The stock has a market capitalization of $5.60 billion, a price-to-earnings ratio of 10.10, a PEG ratio of 0.96 and a beta of 1.56.

Crocs (NASDAQ:CROX - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The textile maker reported $4.55 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.20. Crocs had a return on equity of 47.75% and a net margin of 14.64%.The firm had revenue of $1.18 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same quarter in the previous year, the firm earned ($8.82) EPS. The business's quarterly revenue was up 2.6% on a year-over-year basis. Crocs has set its FY 2026 guidance at 13.700-14.000 EPS and its Q3 2026 guidance at 3.200-3.300 EPS. As a group, sell-side analysts forecast that Crocs, Inc. will post 13.95 earnings per share for the current fiscal year.

Insider Buying and Selling at Crocs

In other Crocs news, CEO Andrew Rees sold 19,072 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $138.91, for a total value of $2,649,291.52. Following the completion of the sale, the chief executive officer owned 713,293 shares in the company, valued at $99,083,530.63. This trade represents a 2.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Beth Kaplan acquired 885 shares of the stock in a transaction dated Tuesday, September 15th. The shares were purchased at an average price of $112.12 per share, for a total transaction of $99,226.20. Following the completion of the purchase, the director directly owned 15,259 shares in the company, valued at $1,710,839.08. The trade was a 6.16% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Corporate insiders own 3.10% of the company's stock.

Hedge Funds Weigh In On Crocs

A number of institutional investors have recently bought and sold shares of the business. Baird Financial Group Inc. lifted its position in shares of Crocs by 450.1% in the second quarter. Baird Financial Group Inc. now owns 166,345 shares of the textile maker's stock valued at $20,068,000 after buying an additional 136,106 shares during the last quarter. Legal & General Group Plc acquired a new position in shares of Crocs during the 2nd quarter worth approximately $8,129,000. Bank of America Corp DE bought a new stake in Crocs in the 2nd quarter valued at $33,820,000. Himalaya Capital Management LLC acquired a new stake in Crocs during the 4th quarter valued at $53,720,000. Finally, WINTON GROUP Ltd acquired a new stake in Crocs during the 2nd quarter valued at $1,556,000. Institutional investors and hedge funds own 93.44% of the company's stock.

Crocs Company Profile

(Get Free Report)

Crocs, Inc is a global footwear company best known for its molded clogs made from Croslite, a proprietary material designed to provide lightweight comfort and water resistance. The company's product portfolio also includes sandals, slides, boots, sneakers and other casual footwear, along with Jibbitz charms and accessories that allow consumers to personalize Crocs shoes.

Founded in 2002, Crocs sells its products through company-operated and partner retail stores, e-commerce websites, wholesale partners and third-party digital marketplaces.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Crocs Right Now?

Before you consider Crocs, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Crocs wasn't on the list.

While Crocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines